Rothschild Capital Partners LLC Acquires New Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Rothschild Capital Partners LLC purchased a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 596 shares of the medical equipment provider's stock, valued at approximately $311,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in ISRG. Bennett Selby Investments LP boosted its position in Intuitive Surgical by 3.9% during the fourth quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider's stock valued at $234,000 after acquiring an additional 17 shares during the last quarter. Onefund LLC boosted its position in shares of Intuitive Surgical by 1.9% during the 4th quarter. Onefund LLC now owns 947 shares of the medical equipment provider's stock valued at $494,000 after purchasing an additional 18 shares in the last quarter. LVW Advisors LLC grew its stake in Intuitive Surgical by 1.3% during the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider's stock worth $756,000 after purchasing an additional 19 shares during the period. Wesbanco Bank Inc. increased its holdings in Intuitive Surgical by 1.6% in the fourth quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider's stock worth $635,000 after purchasing an additional 19 shares in the last quarter. Finally, Journey Strategic Wealth LLC boosted its holdings in shares of Intuitive Surgical by 1.9% during the 4th quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider's stock worth $542,000 after buying an additional 19 shares in the last quarter. 83.64% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, VP Fredrik Widman sold 810 shares of the business's stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $573.78, for a total transaction of $464,761.80. Following the completion of the transaction, the vice president now owns 473 shares of the company's stock, valued at approximately $271,397.94. The trade was a 63.13 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Brian Edward Miller sold 8,900 shares of the stock in a transaction that occurred on Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the completion of the sale, the executive vice president now owns 5,758 shares in the company, valued at $2,793,033.06. This represents a 60.72 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 30,913 shares of company stock valued at $15,981,143. Company insiders own 0.70% of the company's stock.

Analyst Ratings Changes

A number of research firms recently issued reports on ISRG. Bernstein Bank boosted their target price on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an "overweight" rating in a research report on Monday, January 27th. Barclays reduced their target price on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a research note on Thursday, April 24th. Royal Bank of Canada dropped their price target on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 23rd. BTIG Research set a $560.00 price objective on Intuitive Surgical and gave the company a "buy" rating in a research note on Monday, April 14th. Finally, Piper Sandler lowered their target price on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 23rd. Five research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $598.95.

Intuitive Surgical Trading Down 1.1 %

Shares of ISRG stock traded down $5.87 during trading hours on Wednesday, hitting $509.02. 482,407 shares of the company were exchanged, compared to its average volume of 1,613,066. The firm has a fifty day simple moving average of $508.20 and a 200 day simple moving average of $533.13. Intuitive Surgical, Inc. has a 52-week low of $367.39 and a 52-week high of $616.00. The stock has a market capitalization of $182.44 billion, a price-to-earnings ratio of 79.41, a P/E/G ratio of 5.85 and a beta of 1.55.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.71 by $0.10. The company had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same quarter last year, the firm posted $1.50 EPS. Sell-side analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.